Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients

European Journal of Gynaecological Oncology

Volumn 18, Issue 5, 1997, Pages 397-399

  Yasasever, V ^a   Dincer M ^a   Camlica H ^a   Duranyildiz, D ^a   Dalay, N ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Oncology Institute   (Turkey)

Author keywords

Breast cancer; CA 15 3; PHI

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE 6 PHOSPHATE ISOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS;

ADULT; AGED; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EVALUATION STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030875363     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bodansky O.: "Serum phosphohexose isomerase in cancer. I. method of determination and establishment of range of normal values". Cancer, 1954, 7, 1191.
2. American Society of Clinical Oncology: "Clinical practice guidelines for the use of tumor markers in breast cancer and colorectal cancer". J. Clin. Oncol, 1966, 14, 2843.
3. Bodansky O.: "Serum phosphohexose isomerase in cancer. II. as an index of tumor growth in metastatic carcinoma of the breast". Cancer, 1954, 7, 1200.
4. Rees K. R., Slater T. F., Gibbs D. F., Stagg B. H.: "A modified assay for 6-phosphogluconate dehydrogenase in samples of vaginal fluid from women with and without gynecologic cancer". Am. J. Obstet. Gynecol., 1970, 106, 857.
5. Gregoire A. T., Moran M. J., Marjanovic M.: "The glucose-phosphate isomerase content of human cervical mucus of women using either steroid contraceptives, an intrauterine device, or no contraception". Fertil. Steril., 1972, 23, 626.
6. Weber G., Cantero A.: "Glucose-6-phosphate utilization in hepatoma, regenerating and newborn rat liver, and in the liver of the fed and tasted normal rats". Cancer Res., 1957, 17, 995.
7. Tan C. O, Cohen J., West M., Zimmerman H. J.: "Serum enzymes in disease. XIV. Abnormality of levels of transaminases and glycolytic and oxidative enzymes and of liver function as related to the extent of metastatic carcinoma of liver". Cancer. 1963, 16, 1373.
8. Schwartz M. A., West M., Walsh W., Zimmerman H. J.: "Serum enzymes in disease. VII. Glycolytic and oxidative enzymes and transaminases in patients with gastrointestinal carcinoma". Cancer, 1962, 15, 346.
9. Schwartz M. A., Walsh W., West W., Zimmerman H. J.: "Serum enzymes in disease. VII. Glycolytic and oxidative enzymes and transaminases in patients with carcinoma of head, neck and esophagus". Cancer, 1962, 15, 927.
10. Bodansky O.: "Serum phosphohexose isomerase in cancer. III. as an index of tumor growth in metastatic carcinoma of prostate". Cancer, 1955, 8, 1087.
11. Schwartz M. K., Greenberg E., Bodansky O.: "Comparative values of phosphatases and other serum enzymes in following patients with prostatic carcinoma. Consideration of phosphohexose isomerase. glutamic oxalacetic transaminase, isocitric dehydrogenase and acid and alkaline phosphatases". Cancer, 1963, 16, 583.
12. Jophlin G. F., Jegatheeson K.: "Serum glycolytic enzymes and acid phosphatases in mammary carcinomatosis". Br. Med. J., 1962, 827, 1.
13. Dinman B. D., Fox C. F., Frajola W. J., Rabor A.: "Serum enzymes and B12 changes in CC1 hepatotoxicity". Arch. Environ. Health, 1962, 4, 168.
14. Bueding E., MacKinnon J. A : "Studies of the phosphoglucose isomerase of Schistosomamansoni". J. Biol. Chem., 1955, 215, 507.
15. Committee on enzymes of the Scandinavian society for clinical chemistry and clinical physiology: "Recommended method for the determination of γ-glutamyl transferase in blood". Scand. J. Clin. Lab. Invest., 1976, 36, 119.
16. Zwavelling A , Albers G. H., Felthuis W , Herman J.: "An evaluation of routine follow-up detection of breast cancer recurrences". J Surg. Oncol., 1987, 34, 194.
17. Stierer M., Rosen H. R.: "Influence of early diagnosis on prognosis of recurrent breast cancer". Cancer, 1989, 64, 1128.
18. Hayes D. F., Zurawski V. E., Kufe D. W.: "Comparison of circulating CA 15-3 and carcinoembryonic antigen levels in patients with breast cancer". J. Clin. Oncol., 1986, 4, 1542.
19. Colomer R., Lianes P., Ruibal A., Cortes-Funes H., Salvador L., Hornedo J : "Circulating CA 15-3 levels in patient with breast cancer predict relapse and correlate with metastatic tumor burden (Abstract)". Proc. Am. Soc. Clin. Oncol., 1988, 7, 20.
20. Martin E. W., Kibbey W. E., Divecchia L.: "Carcinoembryonic antigen: clinical and historical aspects. Cancer, 1976, 37, 62.
21. Nicolini A., Capri A. D., Marco G., Giulani L., Giordani R., Palla S. A.: "Rational postoperative follow-up with CEA, TPA and urinary hydroxyproline in breast cancer patients". Cancer, 1989, 63, 2037.
22. Pectasides D., Pavlidis N., Gogou L., Antoniou F., Nicolaides C., Tsikalakis D.: "Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients" Am. J. Clin. Oncol., 1996, 19, 459.